Kyowa Kirin Co., Ltd.: all 233 studies

Page 2 of 3. Open to participants first (13), then studies with results posted, then the rest; newest registration first within each.

• A Phase 3 Study of Bardoxolone Methyl in Patients With Diabetic Kidney Disease; AYAME StudyTerminatedNCT03550443Phase 3
• Gene Therapy With Modified Autologous Hematopoietic Stem Cells for the Treatment of Patients With Mucopolysaccharidosis Type I, Hurler VariantActive, not recruitingNCT03488394Phase 1/2
• The Combination Effect of Citicoline and Omega-3CompletedNCT03444662Not applicable
• An Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®)CompletedNCT03433560
• A Safety and Efficacy Study of Cryopreserved OTL-200 for Treatment of Metachromatic Leukodystrophy (MLD)CompletedNCT03392987Phase 2
• Cognitive Effects of Citicoline in Men and Women With Age-Associated Memory ImpairmentCompletedNCT03369925Not applicable
• Phase 2 Study of KHK2375 in Subjects With Advanced or Recurrent Breast CancerCompletedNCT03291886Phase 2
• A Study of KRN23 in Pediatric Patients With X-linked Hypophosphatemic Rickets/OsteomalaciaCompletedNCT03233126Phase 3
• A Study of KW-0761 in Subjects With HTLV-1 Associated Myelopathy (HAM)TerminatedNCT03191526Phase 3
• Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPTCompletedNCT03123406Phase 4
• A Phase 1 Study of KHK4083 in Subjects With Atopic DermatitisCompletedNCT03096223Phase 1
• A Repeated Dose Study of KHK6640 in Japanese Patients With Alzheimer's DiseaseCompletedNCT03093519Phase 1
• A Study of Brodalumab in Subjects With Axial Spondyloarthritis (axSpA)CompletedNCT02985983Phase 3
• A Phase 1 Study of KHK4083 in Healthy Volunteers and Subjects With Ulcerative ColitisCompletedNCT02985593Phase 1
• A Study of KHK4827 (Brodalumab) in Subjects With Moderate to Severe Psoriasis in KoreaCompletedNCT02982005Phase 3
• A Study of KW-6356 in Subjects With Early Parkinson's DiseaseCompletedNCT02939391Phase 2
• Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP)CompletedNCT02868099Phase 3
• Evaluating the Pharmacokinetics and Pharmacodynamics of Romiplostim in Patients With Immune Thrombocytopenia (ITP)CompletedNCT02868060Phase 1/2
• KHK2455 Alone and in Combination With Mogamulizumab in Subjects With Locally Advanced or Metastatic Solid TumorsCompletedNCT02867007Phase 1
• Naloxegol Health Outcome Post Authorisation Safety StudyTerminatedNCT02813369
• Naloxegol Drug Utilization Post Authorisation Safety StudyCompletedNCT02813148
• Study of Romiplostim(AMG531) in Subjects With Aplastic AnemiaCompletedNCT02773290Phase 2/3
• Study of Benralizumab (KHK4563) in Patients With Eosinophilic Chronic RhinosinusitisCompletedNCT02772419Phase 2
• A Study of KRN23 in Subjects With Tumor-Induced Osteomalacia or Epidermal Nevus SyndromeCompletedNCT02722798Phase 2
• Citicoline Effects on Cortical Membrane Structure and FunctionCompletedNCT02705066Not applicable
• Study of KHK2375 in Subjects With Advanced or Recurrent Breast CancerCompletedNCT02623751Phase 1
• A Study to Evaluate Abuse Potential of IstradefyllineCompletedNCT02609477Phase 1
• Phase 3 Study of KHK7580CompletedNCT02549417Phase 3
• Phase 3 Study of KHK7580CompletedNCT02549404Phase 3
• Phase 3 Study of KHK7580CompletedNCT02549391Phase 2/3
• Study of Combination Therapy With Mogamulizumab (KW-0761) and Nivolumab (ONO-4538/BMS-936558) in Subjects With Advanced Solid TumorsCompletedNCT02476123Phase 1
• A Single Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease.CompletedNCT02377713Phase 1
• The Phase II Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes; TSUBAKI StudyCompletedNCT02316821Phase 2
• Study of Mogamulizumab + MEDI4736 (Durvalumab) and Mogamulizumab + Tremelimumab in Subjects w/ Advanced Solid TumorsCompletedNCT02301130Phase 1
• Effect of Mild Hepatic Impairment on the Pharmacokinetics of IstradefyllineCompletedNCT02256033Phase 1
• Phase 2 Study of KHK7580CompletedNCT02216656Phase 2
• A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/OsteomalaciaCompletedNCT02181764Phase 1
• Study of KHK2823 in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)TerminatedNCT02181699Phase 1
• The Effect of Rifampin on the Metabolism of Istradefylline in Healthy Volunteers.CompletedNCT02174250Phase 1
• Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal DialysisCompletedNCT02143271Phase 1
• A Study of Single and Multiple Doses of KHK6640 in Subjects With Prodromal or Mild to Moderate Alzheimer's DiseaseCompletedNCT02127476Phase 1
• Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC PatientsCompletedNCT02099591Phase 1
• Observational Study for Non-motor Symptoms and Treatment in Parkinson's Disease PatientsCompletedNCT02073981
• A Phase 3 Clinical Study of KHK 4827CompletedNCT02052609Phase 3
• A Randomized Double-blind, Placebo-controlled Japanese Phase III Trial of ARQ 197 in Hepatocellular Carcinoma (HCC)CompletedNCT02029157Phase 3
• Phase 2 Study of KHK4577CompletedNCT02004119Phase 2
• Phase 1/2 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving HemodialysisCompletedNCT01935856Phase 1/2
• Two-Part, Open-Label, Multi-Center, Phase 1/2 Study of BIW-8962 as Monotherapy in Subjects With Lung CancerTerminatedNCT01898156Phase 1/2
• An Open-label, Non-controlled Study of KHK4827 in Subjects With PsoriasisCompletedNCT01782937Phase 3
• A Phase 3 Clinical Study of KHK4827CompletedNCT01782924Phase 3
• A Phase 2 Clinical Study of KHK4827CompletedNCT01748539Phase 2
• Patient Satisfaction and Quality of Life Impact - PecFent®Status unknownNCT01698645
• Patient Satisfaction and Quality of Life Impact - PecFent®Status unknownNCT01693328
• Study of ARQ 197 in Hepatocellular Carcinoma (HCC)CompletedNCT01656265Phase 1
• Along-term Study of OPC-262 in Patients With Type 2 DiabetesCompletedNCT01634282Phase 3
• Study of KW-0761 (Mogamulizumab) in Subjects With Previously Treated Peripheral T-cell Lymphoma (PTCL)CompletedNCT01611142Phase 2
• Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 YearsWithdrawnNCT01596426Phase 1
• Pharmacokinetics and Safety of Sancuso and IV Granisetron in Pediatrics Aged 6 to 12 YearsWithdrawnNCT01596413Phase 1
• Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 13 to 17 YearsCompletedNCT01596400Phase 1
• ARQ 197 Plus Erlotinib in Patient With Locally Advanced or Metastatic EGFR Mutation-positive Non-small-cell Lung CancerCompletedNCT01580735Phase 2
• A Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes MellitusTerminatedNCT01574365Phase 2
• A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes MellitusTerminatedNCT01572610Phase 2
• Gene Therapy for Metachromatic Leukodystrophy (MLD)CompletedNCT01560182Phase 1/2
• A Comparative Study of KHK6188CompletedNCT01544296Phase 2
• Phase 1 Study of KHK2898 in Subjects With Advanced Solid TumorsTerminatedNCT01516645Phase 1
• A Clinical Study of KRN321 in Adult Subjects With Myelodysplastic SyndromeCompletedNCT01497145Phase 2
• A Clinical Pharmacology of KHK4827 in Healthy Volunteers and Subject With Moderate to Severe PsoriasisCompletedNCT01488201Phase 1
• An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary HyperparathyroidismCompletedNCT01460030Phase 3
• Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid TumorsCompletedNCT01447732Phase 1
• A Phase IIa Study of KHK4563CompletedNCT01412736Phase 2
• An Open-label Study of KW-3357CompletedNCT01384903Phase 3
• A Phase 3 Clinical Study of KW-3357 in Patients With DICTerminatedNCT01384409Phase 3
• A Clinical Study of KW-3357 in Patients With DICCompletedNCT01384396Phase 3
• A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study of ARQ 197 Plus Erlotinib Versus Placebo Plus ErlotinibTerminatedNCT01377376Phase 3
• A Study of LY2523355 in Patients With Solid CancerCompletedNCT01358019Phase 1
• A Comparative Study of KW-2246CompletedNCT01326689Phase 3
• Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian CancerTerminatedNCT01279291Phase 1
• A Study of ARQ 197 in Combination With ErlotinibCompletedNCT01251796Phase 1
• Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast CancerTerminatedNCT01199367Phase 1
• A Phase 3 Study of OPC-262 in Patients With Type 2 DiabetesCompletedNCT01193179Phase 3
• Study of KW-0761 in Subjects With CCR4-positive Peripheral T/NK-cell LymphomaCompletedNCT01192984Phase 2
• Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15CompletedNCT01173887Phase 2
• A Clinical Pharmacology Study of Saxagliptin in Patients With Type 2 Diabetes MellitusCompletedNCT01162876Phase 3
• Study of ARQ 197 MonotherapyCompletedNCT01152645Phase 2
• Effect of External Heat on a Transdermal Granisetron Patch in Pharmacokinetics (PK) of Healthy SubjectsCompletedNCT01073696Phase 1
• A Study of ARQ 197 in Combination With ErlotinibCompletedNCT01069757Phase 1
• Extended Long-Term Safety Study of KW-6500CompletedNCT01063621Phase 3
• Placebo-Controlled Double-Blind Crossover Comparative Study of KW-6500CompletedNCT01058291Phase 3
• A Study of OPC-262 in Patients With Type 2 DiabetesCompletedNCT01046318Phase 3
• A Study of OPC-262 in Patients With Type 2 DiabetesCompletedNCT00997282Phase 2/3
• Mineral and Bone Disorders Outcomes in Stage 5D of Chronic Kidney DiseaseCompletedNCT00995163
• Study of KRN951 in Patients With Solid TumorsCompletedNCT00970411Phase 1
• Long-Term Safety Study of KW-6002 (Istradefylline) in Parkinson's Disease PatientsCompletedNCT00957203Phase 3
• Study of KW-6002 (Istradefylline) for the Treatment of Parkinson's Disease in Patients Taking LevodopaCompletedNCT00955526Phase 3
• Long-Term Safety Study of KW-6500 in Patients With Parkinson's DiseaseCompletedNCT00955318Phase 3
• A Long-Term, Safety Study With a Flexible Dose Range of KW-6002 in Patients With Motor Response Complications on Levodopa/Carbidopa TherapyCompletedNCT00955045Phase 2/3
• A Study of KW-3357 in Congenital Antithrombin DeficiencyCompletedNCT00938288Phase 1
• Safety Study to Evaluate KW-2450 in Subjects With Advanced Solid TumorCompletedNCT00921336Phase 1
• Safety Study of Electrocardiogram (ECG) Effects of Sancuso® (Granisetron TDS)CompletedNCT00890565Phase 1
• PK, Tolerability and Safety of the Co-administration of Sancuso® (Transdermal Granisetron) and IV GranisetronCompletedNCT00873197Phase 1

← Kyowa Kirin Co., Ltd. overview and focus areas